#accesstomedicines #newmedicines #PharmaNews #MostFavouredNation #MFN #MFNpricingpolicy #WAITIndicator #medicinesaccess #globalpricingreforms #MFNpolicy #pharma #capitalinvestments #clinicaltrials #publicreimbursement #drugapprovals #EMA #EFPIA #EUpolicy #Drugpricing #MarketAccess
zurl.co/zQnRR
zurl.co/zQnRR
European study shows inequality in access to new medicines
Trade organisation EFPIA says disparities in access to new medicines in Europe may be exacerbated by the US's Most-Favoured Nation (MFN) policy.
pharmaphorum.com
May 21, 2026 at 9:08 AM
#Drugpricing #MFN #MostFavouredNation #Alcon #Astellas #BeOne #BridgeBiotherapeutics #CSL #KyowaKirin #SunPharma #Teva #UCB #MostFavouredNationpricingdeals #MFNpolicy #pharmaindustry #tariffs #GENEROUSprogramme #Medicaid #GLOBE #GUARD #APIs #InflationReductionAct
zurl.co/qxnTx
zurl.co/qxnTx
White House signs pricing deals with nine more pharmas
Nine mid-sized pharmas have signed up for the Trump administration's Most Favoured Nation (MFN) pricing deals, pledging almost $20bn in investments.
pharmaphorum.com
September 9, 2026 at 8:21 AM
#EUdrugpricingpolicy #Drugpricing #EU #EFPIA #reimbursement #HEOR #EUpolicy #UKpolicy #USpolicy #patientaccess #newmedicines #innovativedrugs #reimbursement #medicinesspending #medicinepricingpolicies #drugprices #MostFavouredNationpolicy #MFNpolicy #costeffectivenesscalculations
zurl.co/byfmm
zurl.co/byfmm
EFPIA report adds to pressures on EU drug pricing policy
Pharma trade body EFPIA says access to new medicines is worsening across Europe, as it makes the socioeconomic case for spending more on novel drugs
pharmaphorum.com
June 25, 2026 at 9:06 AM
#MostFavouredNationpricing #MFNpricing #MFNpolicy #USpharma #Drugpricing #MFN #Tariffs #accessframeworks #brandedmedicines #MFNframework #MFNthresholds #MFNcalculations #generics #APIs #pharmasupplychains #tariffadvantagedpathways #USUKEconomicProsperityDeal #MFNagreements
zurl.co/OcqZ6
zurl.co/OcqZ6
US pharma MFN and tariff dynamics: What EU and UK leaders need to know
Europe and the United Kingdom are entering a period of direct exposure to US policy choices, and the implications are significant and immediate.
pharmaphorum.com
January 20, 2026 at 9:46 AM
#pharmanews #pharmaindustry #Pharmatariffs #Trump #tariffrates #pharmaceuticalimports #drugpricing #Pfizer #mostfavourednationpolicy #MFNpolicy #TrumpRx #directtoconsumer #MFNprices #innovativemedicines #PharmaceuticalRandD #Pharmaceuticalmanufacturing #EliLilly #pharmaspecificlevies
zurl.co/CG3Ji
zurl.co/CG3Ji
Pharma tariffs yet to emerge as Trump seeks more deals
Donald Trump looks set to delay the introduction of his tariffs on pharma imports in order to negotiate more deals with drugmakers on drug pricing.
pharmaphorum.com
October 3, 2025 at 8:40 AM
Your liver matters, and so does access to the medicines that protect it.
New data shows U.S. patients get innovative treatments years sooner than patients in other countries. #MFNpolicy
For liver cancer, hepatitis B/C, and MASLD/MASH, that speed saves lives. Report: cdn.aglty.io/phrma/Attach...
New data shows U.S. patients get innovative treatments years sooner than patients in other countries. #MFNpolicy
For liver cancer, hepatitis B/C, and MASLD/MASH, that speed saves lives. Report: cdn.aglty.io/phrma/Attach...
May 13, 2026 at 4:49 PM
Your liver matters, and so does access to the medicines that protect it.
New data shows U.S. patients get innovative treatments years sooner than patients in other countries. #MFNpolicy
For liver cancer, hepatitis B/C, and MASLD/MASH, that speed saves lives. Report: cdn.aglty.io/phrma/Attach...
New data shows U.S. patients get innovative treatments years sooner than patients in other countries. #MFNpolicy
For liver cancer, hepatitis B/C, and MASLD/MASH, that speed saves lives. Report: cdn.aglty.io/phrma/Attach...